Cost-Effectiveness Analysis of Oxaliplatin Plus Fluorouracil/Leucovorin (Folfox4) Compared to Sorafenib for Treatment of Advanced Hepatocellular Carcinoma Patients in China

Nov 1, 2016, 00:00
10.1016/j.jval.2016.08.277
https://www.valueinhealthjournal.com/article/S1098-3015(16)30857-9/fulltext
Title : Cost-Effectiveness Analysis of Oxaliplatin Plus Fluorouracil/Leucovorin (Folfox4) Compared to Sorafenib for Treatment of Advanced Hepatocellular Carcinoma Patients in China
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)30857-9&doi=10.1016/j.jval.2016.08.277
First page : A889
Section Title : Disease-Specific Studies
Open access? : No
Section Order : 2739
Categories :
Tags :
Regions :
ViH Article Tags :